Status:
RECRUITING
Study of the Thyroid Function and Echostructural Morphology in Patients Affected With Rasopathies (ECORAS2023)
Lead Sponsor:
University of Bari Aldo Moro
Conditions:
RASopathy
Eligibility:
All Genders
3-25 years
Brief Summary
The study aims to evaluate the prevalence of thyroid disease, particularly with autoimmune pathogenesis (isolated hyperthyrotropinemia, hyperthyroidism, hypothyroidism, thyroid nodules) and/or morphos...
Detailed Description
All patients will undergo blood sampling aimed at studying thyroid function and autoimmunity (TSH, fT3, fT4, anti-TPO, anti-TG, anti-TSH receptor antibodies) and biomarkers of bone metabolism (calcium...
Eligibility Criteria
Inclusion
- Genetically confirmed RASopathy
- Age 3-25 years
Exclusion
- Previous radiotherapy treatments, known exposure to ionizing radiation
- Iodine deficiency
- Use of iodine-based compounds or drugs that interfere with thyroid function
- Congenital hypothyroidism/hyperthyroidism
- Severe obesity with metabolic complications
Key Trial Info
Start Date :
January 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT06489067
Start Date
January 15 2024
End Date
June 30 2024
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bari
Bari, Italy, 70124